期刊
EMERGING INFECTIOUS DISEASES
卷 17, 期 11, 页码 2043-2046出版社
CENTERS DISEASE CONTROL
DOI: 10.3201/eid1711.110787
关键词
-
Oseltamivir is 1 of 2 antiviral medications available for the treatment of influenza B virus infections. We describe and characterize a cluster of influenza B viruses circulating in North Carolina with a mutation in the neuraminidase active site that may reduce susceptibility to oseltamivir and the investigational drug peramivir but not to zanamivir.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据